Study of the Safety and Biological Activity of OncoVEXGM-CSF in Combination with Radiotherapy and Cisplatin in the Treatment of Locally Advanced Epithelial Cancer of the Head and Neck

Sponsor ID

004-04

Clinicaltrials.gov ID

EUCTIS ID

N/A

EudraCT ID

N/A

Study Details

Phase

Phase 1/Phase 2

Product

talimogene laherparepvec (T-VEC)

Type

Interventional

Masking

N/A

Enrollment

N/A

Additional Study Details

Primary Outcome Measures

Not Available

Secondary Outcome Measures

Not Available

Study Synopsis

Available Language(s): English

No locations found.